Loading clinical trials...
Loading clinical trials...
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanderbilt University Medical Center
NCT07274631 · Chronic Obstructive Pulmonary Disease, Asthma, and more
NCT05951478 · Primary Ciliary Dyskinesia
NCT07288827 · Primary Ciliary Dyskinesia, Healthy
NCT06959251 · Primary Ciliary Dyskinesia
NCT07417267 · Primary Ciliary Dyskinesia (PCD), Cystic Fibrosis (CF)
Vanderbilt Children's hospital
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions